Evidence map›Paper›PMID 18454191›Full record

ArticlePLoS genetics2008

DNA damage activates the SAC in an ATM/ATR-dependent manner, independently of the kinetochore.

Eun Mi Kim, Daniel J Burke

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. A novel role for ATR/Rad3 in G1 phase.Scientific reports · 2018
    Article
  16. G3 (Bethesda, Md.) · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eun Mi KimDepartment of Biochemistry and Molecular Genetics, University of Virginia Medical Center, Charlottesville, Virginia, United States of America.
Daniel J Burke
University of Virginia Medical Center · US

Funding

GENETIC CONTROL OF MITOTIC SPINDLE ASSEMBLY AND FUNCTIONR01GM040334 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BURKE, DANIEL J · 1993 to 2005
$1.4M
GENETIC ANALYSIS OF REGULATED TUBULIN SYNTHESISR29GM040334 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BURKE, DANIEL J · 1988 to 1993
–
NIGMS NIH HHS GM40334NIGMS NIH HHS R01 GM040334
6 · The paper itself

Abstract

The DNA damage checkpoint and the spindle assembly checkpoint (SAC) are two important regulatory mechanisms that respond to different lesions. The DNA damage checkpoint detects DNA damage, initiates protein kinase cascades, and inhibits the cell cycle. The SAC relies on kinetochore-dependent assembly of protein complexes to inhibit mitosis when chromosomes are detached from the spindle. The two checkpoints are thought to function independently. Here we show that yeast cells lacking the DNA damage checkpoint arrest prior to anaphase in response to low doses of the DNA damaging agent methyl methane sulfonate (MMS). The arrest requires the SAC proteins Mad1, Mad2, Mad3, Bub1, and Bub3 and works through Cdc20 and Pds1 but unlike the normal SAC, does not require a functional kinetochore. Mec1 (ATR) and Tel1 (ATM) are also required, independently of Chk1 and Rad53, suggesting that Mec1 and Tel1 inhibit anaphase in response to DNA damage by utilizing SAC proteins. Our results demonstrate cross-talk between the two checkpoints and suggest that assembling inhibitory complexes of SAC proteins at unattached kinetochores is not obligatory for their inhibitory activity. Furthermore, our results suggest that there are novel, important targets of ATM and ATR for cell cycle regulation.

Indexed as

DNA DamageAnaphaseCell CycleCell Cycle ProteinsDNA, FungalGenes, FungalIntracellular Signaling Peptides and ProteinsKinetochoresMad2 ProteinsMethyl MethanesulfonateModels, BiologicalMutationNuclear ProteinsProtein Serine-Threonine KinasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsBub1 spindle checkpoint proteinBUB3 protein, S cerevisiaeCell Cycle ProteinsDNA, FungalIntracellular Signaling Peptides and ProteinsMAD1 protein, S cerevisiaeMad2 ProteinsMAD2 protein, S cerevisiaeMAD3 protein, S cerevisiaeMEC1 protein, S cerevisiaeMethyl MethanesulfonateNuclear ProteinsProtein Serine-Threonine KinasesSaccharomyces cerevisiae ProteinsTEL1 protein, S cerevisiae

Identifiers

PMID18454191
PMCPMC2265443
OpenAlexW2136008846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.